Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

New data presented at Transcatheter Cardiovascular Therapeutics (TCT) 2023 from the TRILUMINATE pivotal trial confirm safety, effectiveness and improvements in quality of life when treating tricuspid regurgitation (a leaky valve) with TriClip, an investigational device in the US

News | Structural Heart

Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves

October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...

October 26, 2023

New clinical data support use of lesion-specific FFRCT for diagnosis and treatment of patients with coronary artery disease

News | Computed Tomography (CT)

TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights

October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

October 26, 2023

News | TCT

Six-Month Clinical Data from DESyne BDS Plus Randomized Controlled Trial (RCT) Presented at TCT 2023 Shines Spotlight on Safety, Effectiveness of World’s First Site-Specific Antithrombotic Drug Therapy

October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...

October 25, 2023

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial

News | TCT

Medtronic Evolut TAVR Platform Outperforms Surgery with Sustained Valve Performance for Low-risk Patients at Four Years

October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...

October 25, 2023

Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality, disabling stroke and rehospitalization at five years

News | Cardiovascular Surgery

Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve

October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...

October 25, 2023

Analysis is first to compare health system-based electronic health record data for treatment of pulmonary embolism with interventional devices

News | Pulmonary Embolism

REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism

October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...

October 25, 2023

Clinical research validates utility of IVL in complex nodular and eccentric calcium

News | Cath Lab

New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

October 25, 2023

WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference

News | Left Atrial Appendage (LAA) Occluders

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...

October 25, 2023

3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA

Feature | Pharmaceuticals | By Christine Book

Hypertrophic Cardiomyopathy Video Series with Christine E. Seidman, MD, FACC, FAHA

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

October 25, 2023

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Receives FDA Approval for Extravascular Defibrillator to Treat Abnormal Heart Rhythms, Sudden Cardiac Arrest

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

October 23, 2023

The ALIGN-AR trial is a landmark prospective, single-arm investigation device exemption (IDE) study designed to assess the safety and efficacy of the Trilogy THV System

News | Cardiovascular Clinical Studies

JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023

October 20, 2023 — JenaValve Technology, Inc., developer and manufacturer of the Trilogy Transcatheter Heart Valve (THV) ...

October 20, 2023

Published late-breaking clinical data presented at TCT 2023

News | Heart Failure

Gene Discoveries Could Help Prevent Deadly Coronary Artery Disease

October 20, 2023 — An international team of scientists has identified nearly a dozen genes that contribute to calcium ...

October 20, 2023

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

Feature | TCT | By Melinda Taschetta-Millane

TCT23 Late-breakers: Full Schedule Announced

Innovation. Connection. Inspiration. The Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the Cardiovas ...

October 20, 2023

The CLAAS System to be highlighted daily at TCT, including a live case presentation by Dr. Shephal Doshi

News | Left Atrial Appendage (LAA) Occluders

Conformal Medical to Present One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study at TCT 2023

October 19, 2023 — Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early ...

October 19, 2023

News | TCT

Results of SAFE-TAVI Clinical Study Anticipated at TCT 2023

October 19, 2023 — OpSens, a medical device cardiology-focused company, has announced that results of the “SAFE-TAVI ...

October 19, 2023